Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.66 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.66 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.66 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.66 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.66 |
| ▸ | SRC | P12931 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.66 |
| ▸ | ADK | P55263 | 1/20 | 0.64 |
| ▸ | RNASEL | Q05823 | 2/20 | 0.63 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.61 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.61 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.61 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.61 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.60 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.60 |
| ▸ | LDHA | P00338 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.60 |
| ▸ | FBP1 | P09467 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tubercidin Triphosphate SCHEMBL12932266 | 0.99 | P2RY1 (0.67) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| Tubercidin Triphosphate SCHEMBL29357683 | 0.99 | P2RY1 (0.67) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL30969941 | 0.92 | P2RY1 (0.70) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL15305338 | 0.92 | P2RY1 (0.70) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL11027033 | 0.92 | P2RY1 (0.70) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL20277526 | 0.92 | P2RY1 (0.70) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL14853624 | 0.92 | P2RY1 (0.65) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL20059185 | 0.91 | P2RX1 (0.59) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL20277545 | 0.88 | ADK (0.67) | P2RY1P2RY2P2RX1P2RX3P2RX2 | |
| SCHEMBL14946181 | 0.86 | P2RY2 (0.65) | P2RY2P2RX3P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4566196-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2025-06-11 | — | — | EP | claimed |
| WO-2024028362-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2024-02-08 | — | — | WO | claimed |
| US-20250392378-A1 | Method, implemented by an aerial or spatial device, for communicating with at least one terminal, and associated device, system and computer program | ORANGE (FR) | 2025-12-25 | — | — | US | disclosed |
| US-20250392376-A1 | Method implemented by a network device for monitoring a resource usage to communicate with at least one terminal, and associated network device, terminal, system and computer program | ORANGE (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4566195-A1 | METHOD, IMPLEMENTED BY AN AIR OR SPACE DEVICE, FOR COMMUNICATING WITH AT LEAST ONE TERMINAL, AND ASSOCIATED DEVICE, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2025-06-11 | — | — | EP | disclosed |
| EP-4566196-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2025-06-11 | — | — | EP | disclosed |
| EP-4566196-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2025-06-11 | — | — | EP | disclosed |
| WO-2024027983-A1 | METHOD, IMPLEMENTED BY AN AIR OR SPACE DEVICE, FOR COMMUNICATING WITH AT LEAST ONE TERMINAL, AND ASSOCIATED DEVICE, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2024-02-08 | — | — | WO | disclosed |
| WO-2024028362-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2024-02-08 | — | — | WO | disclosed |
| WO-2024028362-A1 | METHOD IMPLEMENTED BY A NETWORK DEVICE FOR MONITORING THE USE OF RESOURCES TO COMMUNICATE WITH AT LEAST ONE TERMINAL, AND ASSOCIATED NETWORK DEVICE, TERMINAL, SYSTEM AND COMPUTER PROGRAM | ORANGE (FR) | 2024-02-08 | — | — | WO | disclosed |
| EP-4311240-A2 | PARTITIONING METHOD AND SIGNALING METHOD FOR PARTITIONING A CODING TREE UNIT | ORANGE (FR) | 2024-01-24 | — | — | EP | disclosed |
| CN-113207005-B | Encoding method and apparatus, decoding method and apparatus, and storage medium | 奥兰治 | 2023-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250392378-A1 | Method, implemented by an aerial or spatial device, for communicating with at least one terminal, and associated device, system and computer program | TRRAP, TOMM22, TIMM13 | P2RY1 4662/4885P2RY2 4296/4885P2RX1 4765/4885 |
| US-20250392376-A1 | Method implemented by a network device for monitoring a resource usage to communicate with at least one terminal, and associated network device, terminal, system and computer program | TRHR, TRHDE, ERG | P2RY1 2542/4885P2RY2 2261/4885P2RX1 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.